insights_auto
Why is 207940 up 7.78%?
Dive Deeperchevron_right
207940:KRX
Samsung Biologics Co Ltd
₩ 1,399,000.00
arrow_upward
+7.78%(+101,000.00) 1D
10-р сарын 19, 13:16:16 (GMT+9) · KRW
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 207940...
Open
₩ 1,290,000
High
₩ 1,404,000
Low
₩ 1,269,000
Mkt. cap
67.94ИН
Avg. vol.
49.67 мян
Volume
81.78 мян
P/E ratio
30.48
52-wk high
₩ 1,973,600
52-wk low
₩ 1,110,460
EPS
₩ 45,897
Shares outstanding
46.29 сая
No. of employees
5 мян
Open
₩ 1,290,000
High
₩ 1,404,000
Low
₩ 1,269,000
Mkt. cap
67.94ИН
Avg. vol.
49.67 мян
Volume
81.78 мян
P/E ratio
30.48
52-wk high
₩ 1,973,600
52-wk low
₩ 1,110,460
EPS
₩ 45,897
Shares outstanding
46.29 сая
No. of employees
5 мян
News stories
From web sources and news partners
ad-hoc-news.de
·
3 цагийн өмнө
Samsung Biologics clears 87.88% tender hurdle: what it means for Samsung Biologics stock
Profile
Samsung Biologics Co., Ltd. is a global contract development and manufacturing organization headquartered in Songdo, Incheon, South Korea. The biotech division of Samsung Group, its core services range from late discovery to large-scale commercial manufacturing. The company focuses on monoclonal antibodies, bispecific antibodies, antibody-drug conjugates, and mRNA vaccines.
The company has partnered with pharmaceutical companies such as Pfizer, GlaxoSmithKline, Eli Lilly, AstraZeneca and Bristol-Myers Squibb. Wikipedia
About Samsung Biologics Co Ltd